• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Country Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market Segmentation by Application
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Technology
o Exhibit 06: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 07: Parent market
o Exhibit 08: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 09: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 10: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 11: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 12: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 13: Chart on Japan: Year-over-year growth 2022-2027 (%)
o Exhibit 14: Data Table on Japan: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Regenerative medicine market in Japan 2017 – 2021
o Exhibit 15: Historic Market Size – Data Table on regenerative medicine market in Japan 2017 – 2021 ($ million)
o 4.2 Application Segment Analysis 2017 – 2021
o Exhibit 16: Historic Market Size – Application Segment 2017 – 2021 ($ million)
o 4.3 Technology Segment Analysis 2017 – 2021
o Exhibit 17: Historic Market Size – Technology Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 18: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 19: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 20: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 21: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 22: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 23: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 24: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 25: Chart on Application – Market share 2022-2027 (%)
o Exhibit 26: Data Table on Application – Market share 2022-2027 (%)
o 6.2 Comparison by Application
o Exhibit 27: Chart on Comparison by Application
o Exhibit 28: Data Table on Comparison by Application
o 6.3 Oncology – Market size and forecast 2022-2027
o Exhibit 29: Chart on Oncology – Market size and forecast 2022-2027 ($ million)
o Exhibit 30: Data Table on Oncology – Market size and forecast 2022-2027 ($ million)
o Exhibit 31: Chart on Oncology – Year-over-year growth 2022-2027 (%)
o Exhibit 32: Data Table on Oncology – Year-over-year growth 2022-2027 (%)
o 6.4 Musculoskeletal – Market size and forecast 2022-2027
o Exhibit 33: Chart on Musculoskeletal – Market size and forecast 2022-2027 ($ million)
o Exhibit 34: Data Table on Musculoskeletal – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Chart on Musculoskeletal – Year-over-year growth 2022-2027 (%)
o Exhibit 36: Data Table on Musculoskeletal – Year-over-year growth 2022-2027 (%)
o 6.5 Dermatology – Market size and forecast 2022-2027
o Exhibit 37: Chart on Dermatology – Market size and forecast 2022-2027 ($ million)
o Exhibit 38: Data Table on Dermatology – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Chart on Dermatology – Year-over-year growth 2022-2027 (%)
o Exhibit 40: Data Table on Dermatology – Year-over-year growth 2022-2027 (%)
o 6.6 Immunology and Inflammation and others – Market size and forecast 2022-2027
o Exhibit 41: Chart on Immunology and Inflammation and others – Market size and forecast 2022-2027 ($ million)
o Exhibit 42: Data Table on Immunology and Inflammation and others – Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Chart on Immunology and Inflammation and others – Year-over-year growth 2022-2027 (%)
o Exhibit 44: Data Table on Immunology and Inflammation and others – Year-over-year growth 2022-2027 (%)
o 6.7 Market opportunity by Application
o Exhibit 45: Market opportunity by Application ($ million)
o Exhibit 46: Data Table on Market opportunity by Application ($ million)
• 7 Market Segmentation by Technology
o 7.1 Market segments
o Exhibit 47: Chart on Technology – Market share 2022-2027 (%)
o Exhibit 48: Data Table on Technology – Market share 2022-2027 (%)
o 7.2 Comparison by Technology
o Exhibit 49: Chart on Comparison by Technology
o Exhibit 50: Data Table on Comparison by Technology
o 7.3 Cell and tissue-based – Market size and forecast 2022-2027
o Exhibit 51: Chart on Cell and tissue-based – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Cell and tissue-based – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Cell and tissue-based – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Cell and tissue-based – Year-over-year growth 2022-2027 (%)
o 7.4 Gene therapy – Market size and forecast 2022-2027
o Exhibit 55: Chart on Gene therapy – Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on Gene therapy – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on Gene therapy – Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Gene therapy – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Technology
o Exhibit 59: Market opportunity by Technology ($ million)
o Exhibit 60: Data Table on Market opportunity by Technology ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 61: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Drivers, Challenges, and Trends
o 9.1 Market drivers
o 9.2 Market challenges
o 9.3 Impact of drivers and challenges
o Exhibit 62: Impact of drivers and challenges in 2022 and 2027
o 9.4 Market trends
• 10 Vendor Landscape
o 10.1 Overview
o 10.2 Vendor landscape
o Exhibit 63: Overview on Criticality of inputs and Factors of differentiation
o 10.3 Landscape disruption
o Exhibit 64: Overview on factors of disruption
o 10.4 Industry risks
o Exhibit 65: Impact of key risks on business
• 11 Vendor Analysis
o 11.1 Vendors covered
o Exhibit 66: Vendors covered
o 11.2 Market positioning of vendors
o Exhibit 67: Matrix on vendor position and classification
o 11.3 Astellas Pharma Inc.
o Exhibit 68: Astellas Pharma Inc. – Overview
o Exhibit 69: Astellas Pharma Inc. – Product / Service
o Exhibit 70: Astellas Pharma Inc. – Key news
o Exhibit 71: Astellas Pharma Inc. – Key offerings
o 11.4 Becton Dickinson and Co.
o Exhibit 72: Becton Dickinson and Co. – Overview
o Exhibit 73: Becton Dickinson and Co. – Business segments
o Exhibit 74: Becton Dickinson and Co. – Key news
o Exhibit 75: Becton Dickinson and Co. – Key offerings
o Exhibit 76: Becton Dickinson and Co. – Segment focus
o 11.5 CellSeed Inc.
o Exhibit 77: CellSeed Inc. – Overview
o Exhibit 78: CellSeed Inc. – Product / Service
o Exhibit 79: CellSeed Inc. – Key offerings
o 11.6 Cyfuse Biomedical K.K.
o Exhibit 80: Cyfuse Biomedical K.K. – Overview
o Exhibit 81: Cyfuse Biomedical K.K. – Product / Service
o Exhibit 82: Cyfuse Biomedical K.K. – Key offerings
o 11.7 F. Hoffmann La Roche Ltd.
o Exhibit 83: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 84: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 85: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 86: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 87: F. Hoffmann La Roche Ltd. – Segment focus
o 11.8 FUJIFILM Corp.
o Exhibit 88: FUJIFILM Corp. – Overview
o Exhibit 89: FUJIFILM Corp. – Business segments
o Exhibit 90: FUJIFILM Corp. – Key news
o Exhibit 91: FUJIFILM Corp. – Key offerings
o Exhibit 92: FUJIFILM Corp. – Segment focus
o 11.9 iHeart Japan Corp.
o Exhibit 93: iHeart Japan Corp. – Overview
o Exhibit 94: iHeart Japan Corp. – Product / Service
o Exhibit 95: iHeart Japan Corp. – Key offerings
o 11.10 JCR Pharmaceticals Co. Ltd.
o Exhibit 96: JCR Pharmaceticals Co. Ltd. – Overview
o Exhibit 97: JCR Pharmaceticals Co. Ltd. – Product / Service
o Exhibit 98: JCR Pharmaceticals Co. Ltd. – Key offerings
o 11.11 Nikon Corp.
o Exhibit 99: Nikon Corp. – Overview
o Exhibit 100: Nikon Corp. – Business segments
o Exhibit 101: Nikon Corp. – Key news
o Exhibit 102: Nikon Corp. – Key offerings
o Exhibit 103: Nikon Corp. – Segment focus
o 11.12 ROHTO Pharmaceutical Co. Ltd.
o Exhibit 104: ROHTO Pharmaceutical Co. Ltd. – Overview
o Exhibit 105: ROHTO Pharmaceutical Co. Ltd. – Business segments
o Exhibit 106: ROHTO Pharmaceutical Co. Ltd. – Key offerings
o Exhibit 107: ROHTO Pharmaceutical Co. Ltd. – Segment focus
o 11.13 Sumitomo Pharma Co. Ltd.
o Exhibit 108: Sumitomo Pharma Co. Ltd. – Overview
o Exhibit 109: Sumitomo Pharma Co. Ltd. – Business segments
o Exhibit 110: Sumitomo Pharma Co. Ltd. – Key offerings
o Exhibit 111: Sumitomo Pharma Co. Ltd. – Segment focus
o 11.14 Takara Bio Inc.
o Exhibit 112: Takara Bio Inc. – Overview
o Exhibit 113: Takara Bio Inc. – Product / Service
o Exhibit 114: Takara Bio Inc. – Key offerings
o 11.15 Takeda Pharmaceutical Co. Ltd.
o Exhibit 115: Takeda Pharmaceutical Co. Ltd. – Overview
o Exhibit 116: Takeda Pharmaceutical Co. Ltd. – Product / Service
o Exhibit 117: Takeda Pharmaceutical Co. Ltd. – Key news
o Exhibit 118: Takeda Pharmaceutical Co. Ltd. – Key offerings
o 11.16 Terumo Corp.
o Exhibit 119: Terumo Corp. – Overview
o Exhibit 120: Terumo Corp. – Business segments
o Exhibit 121: Terumo Corp. – Key news
o Exhibit 122: Terumo Corp. – Key offerings
o Exhibit 123: Terumo Corp. – Segment focus
o 11.17 Yokogawa Electric Corp.
o Exhibit 124: Yokogawa Electric Corp. – Overview
o Exhibit 125: Yokogawa Electric Corp. – Business segments
o Exhibit 126: Yokogawa Electric Corp. – Key offerings
o Exhibit 127: Yokogawa Electric Corp. – Segment focus
• 12 Appendix
o 12.1 Scope of the report
o 12.2 Inclusions and exclusions checklist
o Exhibit 128: Inclusions checklist
o Exhibit 129: Exclusions checklist
o 12.3 Currency conversion rates for US$
o Exhibit 130: Currency conversion rates for US$
o 12.4 Research methodology
o Exhibit 131: Research methodology
o Exhibit 132: Validation techniques employed for market sizing
o Exhibit 133: Information sources
o 12.5 List of abbreviations
o Exhibit 134: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Country Market Characteristics
Exhibits4: Executive Summary – Chart on Market Segmentation by Application
Exhibits5: Executive Summary – Chart on Market Segmentation by Technology
Exhibits6: Executive Summary – Chart on Vendor Market Positioning
Exhibits7: Parent market
Exhibits8: Market Characteristics
Exhibits9: Offerings of vendors included in the market definition
Exhibits10: Market segments
Exhibits11: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits12: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits13: Chart on Japan: Year-over-year growth 2022-2027 (%)
Exhibits14: Data Table on Japan: Year-over-year growth 2022-2027 (%)
Exhibits15: Historic Market Size – Data Table on regenerative medicine market in Japan 2017 – 2021 ($ million)
Exhibits16: Historic Market Size – Application Segment 2017 – 2021 ($ million)
Exhibits17: Historic Market Size – Technology Segment 2017 – 2021 ($ million)
Exhibits18: Five forces analysis – Comparison between 2022 and 2027
Exhibits19: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits20: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits21: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits22: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits23: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits24: Chart on Market condition – Five forces 2022 and 2027
Exhibits25: Chart on Application – Market share 2022-2027 (%)
Exhibits26: Data Table on Application – Market share 2022-2027 (%)
Exhibits27: Chart on Comparison by Application
Exhibits28: Data Table on Comparison by Application
Exhibits29: Chart on Oncology – Market size and forecast 2022-2027 ($ million)
Exhibits30: Data Table on Oncology – Market size and forecast 2022-2027 ($ million)
Exhibits31: Chart on Oncology – Year-over-year growth 2022-2027 (%)
Exhibits32: Data Table on Oncology – Year-over-year growth 2022-2027 (%)
Exhibits33: Chart on Musculoskeletal – Market size and forecast 2022-2027 ($ million)
Exhibits34: Data Table on Musculoskeletal – Market size and forecast 2022-2027 ($ million)
Exhibits35: Chart on Musculoskeletal – Year-over-year growth 2022-2027 (%)
Exhibits36: Data Table on Musculoskeletal – Year-over-year growth 2022-2027 (%)
Exhibits37: Chart on Dermatology – Market size and forecast 2022-2027 ($ million)
Exhibits38: Data Table on Dermatology – Market size and forecast 2022-2027 ($ million)
Exhibits39: Chart on Dermatology – Year-over-year growth 2022-2027 (%)
Exhibits40: Data Table on Dermatology – Year-over-year growth 2022-2027 (%)
Exhibits41: Chart on Immunology and Inflammation and others – Market size and forecast 2022-2027 ($ million)
Exhibits42: Data Table on Immunology and Inflammation and others – Market size and forecast 2022-2027 ($ million)
Exhibits43: Chart on Immunology and Inflammation and others – Year-over-year growth 2022-2027 (%)
Exhibits44: Data Table on Immunology and Inflammation and others – Year-over-year growth 2022-2027 (%)
Exhibits45: Market opportunity by Application ($ million)
Exhibits46: Data Table on Market opportunity by Application ($ million)
Exhibits47: Chart on Technology – Market share 2022-2027 (%)
Exhibits48: Data Table on Technology – Market share 2022-2027 (%)
Exhibits49: Chart on Comparison by Technology
Exhibits50: Data Table on Comparison by Technology
Exhibits51: Chart on Cell and tissue-based – Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Cell and tissue-based – Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Cell and tissue-based – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Cell and tissue-based – Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Gene therapy – Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Gene therapy – Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Gene therapy – Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Gene therapy – Year-over-year growth 2022-2027 (%)
Exhibits59: Market opportunity by Technology ($ million)
Exhibits60: Data Table on Market opportunity by Technology ($ million)
Exhibits61: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits62: Impact of drivers and challenges in 2022 and 2027
Exhibits63: Overview on Criticality of inputs and Factors of differentiation
Exhibits64: Overview on factors of disruption
Exhibits65: Impact of key risks on business
Exhibits66: Vendors covered
Exhibits67: Matrix on vendor position and classification
Exhibits68: Astellas Pharma Inc. – Overview
Exhibits69: Astellas Pharma Inc. – Product / Service
Exhibits70: Astellas Pharma Inc. – Key news
Exhibits71: Astellas Pharma Inc. – Key offerings
Exhibits72: Becton Dickinson and Co. – Overview
Exhibits73: Becton Dickinson and Co. – Business segments
Exhibits74: Becton Dickinson and Co. – Key news
Exhibits75: Becton Dickinson and Co. – Key offerings
Exhibits76: Becton Dickinson and Co. – Segment focus
Exhibits77: CellSeed Inc. – Overview
Exhibits78: CellSeed Inc. – Product / Service
Exhibits79: CellSeed Inc. – Key offerings
Exhibits80: Cyfuse Biomedical K.K. – Overview
Exhibits81: Cyfuse Biomedical K.K. – Product / Service
Exhibits82: Cyfuse Biomedical K.K. – Key offerings
Exhibits83: F. Hoffmann La Roche Ltd. – Overview
Exhibits84: F. Hoffmann La Roche Ltd. – Business segments
Exhibits85: F. Hoffmann La Roche Ltd. – Key news
Exhibits86: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits87: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits88: FUJIFILM Corp. – Overview
Exhibits89: FUJIFILM Corp. – Business segments
Exhibits90: FUJIFILM Corp. – Key news
Exhibits91: FUJIFILM Corp. – Key offerings
Exhibits92: FUJIFILM Corp. – Segment focus
Exhibits93: iHeart Japan Corp. – Overview
Exhibits94: iHeart Japan Corp. – Product / Service
Exhibits95: iHeart Japan Corp. – Key offerings
Exhibits96: JCR Pharmaceticals Co. Ltd. – Overview
Exhibits97: JCR Pharmaceticals Co. Ltd. – Product / Service
Exhibits98: JCR Pharmaceticals Co. Ltd. – Key offerings
Exhibits99: Nikon Corp. – Overview
Exhibits100: Nikon Corp. – Business segments
Exhibits101: Nikon Corp. – Key news
Exhibits102: Nikon Corp. – Key offerings
Exhibits103: Nikon Corp. – Segment focus
Exhibits104: ROHTO Pharmaceutical Co. Ltd. – Overview
Exhibits105: ROHTO Pharmaceutical Co. Ltd. – Business segments
Exhibits106: ROHTO Pharmaceutical Co. Ltd. – Key offerings
Exhibits107: ROHTO Pharmaceutical Co. Ltd. – Segment focus
Exhibits108: Sumitomo Pharma Co. Ltd. – Overview
Exhibits109: Sumitomo Pharma Co. Ltd. – Business segments
Exhibits110: Sumitomo Pharma Co. Ltd. – Key offerings
Exhibits111: Sumitomo Pharma Co. Ltd. – Segment focus
Exhibits112: Takara Bio Inc. – Overview
Exhibits113: Takara Bio Inc. – Product / Service
Exhibits114: Takara Bio Inc. – Key offerings
Exhibits115: Takeda Pharmaceutical Co. Ltd. – Overview
Exhibits116: Takeda Pharmaceutical Co. Ltd. – Product / Service
Exhibits117: Takeda Pharmaceutical Co. Ltd. – Key news
Exhibits118: Takeda Pharmaceutical Co. Ltd. – Key offerings
Exhibits119: Terumo Corp. – Overview
Exhibits120: Terumo Corp. – Business segments
Exhibits121: Terumo Corp. – Key news
Exhibits122: Terumo Corp. – Key offerings
Exhibits123: Terumo Corp. – Segment focus
Exhibits124: Yokogawa Electric Corp. – Overview
Exhibits125: Yokogawa Electric Corp. – Business segments
Exhibits126: Yokogawa Electric Corp. – Key offerings
Exhibits127: Yokogawa Electric Corp. – Segment focus
Exhibits128: Inclusions checklist
Exhibits129: Exclusions checklist
Exhibits130: Currency conversion rates for US$
Exhibits131: Research methodology
Exhibits132: Validation techniques employed for market sizing
Exhibits133: Information sources
Exhibits134: List of abbreviations